drugset / Trial / NCT00747071
Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies
RandomizedSingle-groupQuadruple-blindPrevention
Summary
This clinical study is designed to evaluate the safety and efficacy of oral administration of the food additive colostrum derived antibodies to Clostridium difficile for prevention of Clostridium difficile associated disease (CDAD).
Timeline
- Start
- 2011-09
- Primary completion
- 2012-11
- Completion
- 2013-11
Outcome
Outcome not reported
Stopped: “Sponsors decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colostrum | Protein / enzyme biologic | — | Oral |